Recce (Australia) Today

RCE Stock   0.47  0.01  2.17%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 20

 
High
 
Low
Low
Recce is selling for under 0.47 as of the 26th of November 2024; that is 2.17 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.45. Recce has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Recce are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2024 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Recce is entity of Australia. It is traded as Stock on AU exchange. The company has 231.87 M outstanding shares. More on Recce

Moving against Recce Stock

  0.43JPR Jupiter EnergyPairCorr
  0.42ZIP Zip Co LimitedPairCorr
  0.42IAG Insurance AustraliaPairCorr
  0.4OD6 OD6 MetalsPairCorr

Recce Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Recce's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Recce or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
MD CEOJames GAICD
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors)
Recce's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Recce's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Recce can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Recce's financial leverage. It provides some insight into what part of Recce's total assets is financed by creditors.
Liquidity
Recce cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Recce has accumulated 811.19 K in total debt. Debt can assist Recce until it has trouble settling it off, either with new capital or with free cash flow. So, Recce's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Recce sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Recce to invest in growth at high rates of return. When we think about Recce's use of debt, we should always consider it together with cash and equity.

Total Cashflows From Investing Activities

(46,649.35)
Recce (RCE) is traded on Australian Securities Exchange in Australia and employs 10 people. Recce is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 107.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Recce's market, we take the total number of its shares issued and multiply it by Recce's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Recce operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 231.87 M outstanding shares. Recce generates negative cash flow from operations
Check Recce Probability Of Bankruptcy
Ownership Allocation
Recce owns a total of 231.87 Million outstanding shares. Recce has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Recce Ownership Details

Recce Risk Profiles

Although Recce's alpha and beta are two of the key measurements used to evaluate Recce's performance over the market, the standard measures of volatility play an important role as well.

Recce Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Recce without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

Recce Corporate Management

Elected by the shareholders, the Recce's board of directors comprises two types of representatives: Recce inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Recce. The board's role is to monitor Recce's management team and ensure that shareholders' interests are well served. Recce's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Recce's outside directors are responsible for providing unbiased perspectives on the board's policies.
Justin ReynoldsChief OfficerProfile
Arthur KollarasPrincipal ManufacturingProfile
BA BComHead MarketingProfile
John PrendergastExecutive BoardProfile
Maggie NiewidokCompany SecretaryProfile

Additional Tools for Recce Stock Analysis

When running Recce's price analysis, check to measure Recce's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recce is operating at the current time. Most of Recce's value examination focuses on studying past and present price action to predict the probability of Recce's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recce's price. Additionally, you may evaluate how the addition of Recce to your portfolios can decrease your overall portfolio volatility.